Dr. Eng patented the peptide. Amylin Pharmaceuticals eventually licensed and developed it into the first GLP-1 medicine. In 2005, the FDA approved it to treat type 2 diabetes. That 15-year journey — ...

In 2025, as weight-loss drugs entered the Indian market, clinics began launching pre-wedding packages targeted at young women ...

Previously, Louisiana ranked as one of the most obese states. Now, a new report shows that the state's adult obesity rate has ...

Eli Lilly said its experimental combination regimen resulted in greater weight loss than a high dose of its top-selling drug, tirzepatide, alone in a mid-stage trial on patients with obesity and Type ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Eli Lilly's eloralintide plus low‑dose tirzepatide cut weight up to 23.3% and A1C by 2.9% in a 48‑week Phase 2, beating tirzepatide 15 mg alone.

BATON ROUGE — Louisiana obesity rates have dropped significantly since 2024, a new report by Trust for America's Health says. In 2024, Louisiana was ranked third-highest in the country for adult ...

Asking prices have dipped in the past year but remain high compared to 10 years ago, data from Realtor.com shows. The median asking price for a U.S. home was $424,500 in August 2026, according to data ...

Austin, Denver and Los Angeles are among the major markets seeing a decline in median listing prices. Austin, Denver and Los Angeles are among the major markets seeing a decline in median listing ...